Virulence factors, Pathogenesis and Clinical manifestations of Streptococcus pneumoniae

Streptococcus pneumoniae (also known as pneumococcus) is a type of bacteria that can cause various infections, such as pneumonia, meningitis, otitis media, sinusitis, and sepsis. It is one of the most common causes of morbidity and mortality worldwide, especially in children under five years old and adults over 65 years old.

Streptococcus pneumoniae are lancet-shaped, gram-positive, facultative anaerobic bacteria that have more than 100 different serotypes based on their capsular polysaccharide antigens . The capsule is an important virulence factor that helps the bacteria evade the host immune system by preventing phagocytosis and complement activation. However, not all serotypes are equally pathogenic or prevalent. Only a few serotypes account for most of the pneumococcal disease cases in different regions and populations.

Streptococcus pneumoniae can be found in the upper respiratory tract (URT) of healthy people, especially children, without causing any symptoms. This is called colonization or carriage . The rate and duration of colonization vary depending on factors such as age, season, vaccination status, and exposure to other people. Colonization is usually harmless and may even confer some protection against invasive disease by stimulating natural immunity. However, colonization can also lead to infection if the bacteria spread to other parts of the body or if the host defenses are compromised by factors such as viral infections, smoking, chronic diseases, or immunosuppression .

The transmission of Streptococcus pneumoniae occurs through respiratory droplets from coughing or sneezing of infected or colonized people. The bacteria can also be transmitted by direct contact with contaminated secretions or surfaces . The risk of transmission is higher in crowded settings such as schools, daycare centers, nursing homes, and hospitals. The incubation period of pneumococcal disease ranges from one to three days.

The pathogenesis of Streptococcus pneumoniae involves several steps: adhesion to the epithelial cells of the URT, invasion of the host cells or tissues, evasion of the host immune response, and damage to the host cells or tissues by various mechanisms. These steps are mediated by different virulence factors that will be discussed in detail in the next section.

Streptococcus pneumoniae (pneumococcus) is a gram-positive bacterium that can cause serious infections such as pneumonia, meningitis, and septicemia. To successfully colonize and invade the human host, pneumococcus produces several virulence factors that help it evade the immune system and damage the host tissues. Some of the major virulence factors of pneumococcus are:

• Polysaccharide capsule: The capsule is a thick layer of polysaccharides that surrounds the bacterial cell wall. It is the most important virulence factor of pneumococcus, as it protects the bacterium from phagocytosis by preventing the deposition of complement and antibodies on its surface . There are more than 90 different serotypes of pneumococcal capsule, and each one has a specific antigenic structure that determines its immunogenicity and pathogenicity . Antibodies against the capsule are the main mechanism of protection against pneumococcal infections.
• Cell wall associated polymers and proteins: The cell wall of pneumococcus contains various components that can interact with the host cells and trigger inflammatory responses. Some of these components are :
  • Teichoic acid: A polymer of glycerol or ribitol phosphate that binds to epithelial cells and activates the alternative complement pathway.
  • Protein adhesins: Proteins that mediate the attachment of pneumococcus to epithelial cells and facilitate colonization. Some examples are choline-binding proteins (CBPs), such as PspA, PspC, and LytB, and non-CBPs, such as F protein and PsaA.
  • Peptidoglycan: A network of sugars and amino acids that forms the rigid structure of the cell wall. It activates the alternative complement pathway and stimulates the release of pro-inflammatory cytokines.
  • Phosphorylcholine: A molecule that is present on the cell wall teichoic acid and peptidoglycan. It can bind to receptors for platelet-activating factor (PAF) on host cells, such as endothelial cells, leukocytes, platelets, and tissue cells. This allows pneumococcus to enter the cells and escape from immune recognition and clearance. It also facilitates the spread of infection to sequestered sites, such as blood and cerebrospinal fluid.
• Pneumolysin: A toxin that belongs to the family of cholesterol-dependent cytolysins. It is produced by almost all strains of pneumococcus and is released upon bacterial lysis . Pneumolysin can bind to cholesterol-containing membranes of host cells and form pores that disrupt their integrity and function. It can also induce apoptosis, activate complement, inhibit phagocytosis, impair ciliary activity, suppress lymphocyte proliferation, and stimulate the production of pro-inflammatory cytokines . Pneumolysin is a major contributor to tissue damage and inflammation in pneumococcal infections.
• Pili: Hair-like structures that extend from the bacterial surface and enable the attachment of encapsulated pneumococcus to the epithelial cells of the upper respiratory tract . Pili are composed of three proteins: RrgA, RrgB, and RrgC. RrgA is the adhesin that binds to host cell receptors, RrgB is the backbone that forms the pilus shaft, and RrgC is the tip-associated protein that stabilizes the pilus structure. Pili are not present in all strains of pneumococcus, but they have been associated with increased virulence in animal models of infection .
• IgA1 protease: An enzyme that specifically cleaves human IgA1 in the hinge region. IgA1 is the predominant immunoglobulin isotype involved in mucosal immunity in humans. It can bind to pneumococcus and prevent its adherence to epithelial cells. IgA1 protease degrades IgA1 and allows pneumococcus to evade this defense mechanism and colonize mucosal surfaces .
• Autolysins: Enzymes that hydrolyze the components of the bacterial cell wall, such as peptidoglycan. Autolysins are involved in cell division, cell shape maintenance, and cell lysis . The main autolysin in pneumococcus is LytA, which breaks down the peptide cross-links of peptidoglycan and causes bacterial lysis. Autolysis enables the release of pneumolysin and other cell wall fragments that can trigger inflammation and tissue damage . Autolysis also regulates biofilm formation and dispersal by pneumococcus.

These virulence factors work together to enable pneumococcus to colonize, invade, survive, and damage the human host. Understanding their mechanisms and interactions can help develop better strategies for diagnosis, treatment, and prevention of pneumococcal diseases.

Streptococcus pneumoniae is a common inhabitant of the upper respiratory tract of healthy people, especially children. However, under certain conditions, such as impaired mucociliary clearance, viral infection, immunodeficiency, or exposure to a new serotype, the bacteria can invade the lower respiratory tract and cause pneumonia. The bacteria can also spread to other sterile sites, such as the bloodstream, the meninges, the middle ear, and the sinuses, and cause invasive pneumococcal disease (IPD).

The pathogenesis of S. pneumoniae infection involves several steps:

• Transmission and colonization: The bacteria are transmitted from person to person through respiratory droplets or contact with contaminated secretions. The bacteria adhere to the epithelial cells of the nasopharynx by using various surface molecules, such as pili, adhesins, and neuraminidase . The bacteria can also evade the host immune system by producing IgA1 protease, which cleaves the secretory IgA that normally prevents bacterial attachment.
• Invasion and tissue damage: The bacteria can cross the epithelial barrier and enter the bloodstream or other tissues by using phosphorylcholine, which binds to platelet-activating factor receptors on host cells . The bacteria can also cause tissue damage by releasing various factors, such as pneumolysin, hydrogen peroxide, cell wall components (teichoic acid and peptidoglycan), and autolysins . These factors can disrupt cell membranes, activate complement and inflammatory pathways, induce cytokine production, impair ciliary function and phagocytosis, and trigger bacterial lysis and release of more virulence factors .
• Capsular evasion and survival: The bacteria are surrounded by a polysaccharide capsule that protects them from phagocytosis and complement-mediated killing . There are more than 100 serotypes of S. pneumoniae, each with a different capsule structure. The capsule is the main determinant of virulence and immunogenicity of S. pneumoniae. Antibodies against the capsule are protective against infection by the same serotype. However, natural immunity is serotype-specific and does not prevent colonization or infection by other serotypes.

The outcome of S. pneumoniae infection depends on the balance between the bacterial virulence factors and the host immune response. Factors that increase the risk of severe or invasive disease include age (young children and elderly), comorbidities (chronic lung disease, diabetes, heart disease), immunosuppression (HIV infection, cancer treatment), smoking, alcohol abuse, malnutrition, and genetic susceptibility .

Clinical manifestations of Streptococcus pneumoniae

- S. pneumoniae is the most common cause of community-acquired pneumonia, which can present with fever, cough, chest pain, dyspnea, and sputum production. The diagnosis is confirmed by chest radiography and isolation of the organism from blood or sputum cultures. Pneumonia can be complicated by pleural effusion, empyema, lung abscess, or bacteremia.
- S. pneumoniae is also the leading cause of bacterial meningitis in adults and children older than 2 years. Meningitis is a life-threatening infection of the meninges, the membranes that cover the brain and spinal cord. The symptoms include headache, neck stiffness, photophobia, altered mental status, and seizures. The diagnosis is made by lumbar puncture and analysis of cerebrospinal fluid (CSF), which shows increased pressure, elevated protein, decreased glucose, and increased white blood cells. The organism can be detected by Gram stain, culture, or antigen tests of CSF. Meningitis can result in neurological sequelae, such as hearing loss, cognitive impairment, or hydrocephalus.
- S. pneumoniae can also cause otitis media (middle ear infection), sinusitis (sinus infection), conjunctivitis (eye infection), and mastoiditis (infection of the mastoid bone behind the ear). These infections are usually preceded by a viral upper respiratory tract infection that disrupts the normal clearance of bacteria from the mucosa. The symptoms include pain, swelling, redness, discharge, and fever. The diagnosis is based on clinical examination and sometimes culture or imaging tests. These infections can be treated with antibiotics and sometimes require surgical drainage.
- S. pneumoniae can also invade the bloodstream and cause invasive pneumococcal disease (IPD), which is associated with high mortality and morbidity. IPD can manifest as septicemia (blood infection), endocarditis (heart valve infection), pericarditis (heart sac infection), arthritis (joint infection), osteomyelitis (bone infection), or peritonitis (abdominal cavity infection). The risk factors for IPD include immunocompromised states, such as HIV infection, asplenia, sickle cell disease, chronic diseases, such as diabetes mellitus or chronic obstructive pulmonary disease, and advanced age. The diagnosis is based on isolation of the organism from blood or other normally sterile sites. IPD can lead to organ failure, shock, or death.

S. pneumoniae is a major human pathogen that causes a variety of infections ranging from mild to severe. The virulence factors of S. pneumoniae enable it to colonize the mucosa, evade the host immune system, damage the host tissues, and spread to different sites. The clinical manifestations of S. pneumoniae depend on the site and severity of infection and can include pneumonia, meningitis, otitis media, sinusitis, conjunctivitis, mastoiditis, and invasive pneumococcal disease. The treatment of S. pneumoniae infections involves antibiotics and supportive care. The prevention of S. pneumoniae infections relies on vaccination and hygiene measures.

We are Compiling this Section. Thanks for your understanding.